Trial intelligence / Profile preview

Maraviroc for Immune Function Intensification in HIV-1

NCT01049204Phase 4Terminated

Sponsor
St Stephen's AIDS Trust
Start
Jul 2009
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Started Jul 2009; status: terminated.

02

Drugs

maraviroc
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01049204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01049204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call